European industry groups organise opposition to proposed French regulations
This article was originally published in Clinica
European medical device industry associations are urging their members to make formal depositions opposing the French authorities' proposed new requirements for high-risk medical devices. The European Confederation of Medical Devices Associations (EUCOMED) and the International Association of Medical Prosthesis Manufacturers (IAPM) have asked members to lobby their national regulatory authorities to take action.
You may also be interested in...
FDA action awaits Sun’s manufacturing facility in Halol after it failed to adequately address GMP deviations, though India’s top-ranked drug firm appears to have effectively lowered its dependence on the site that has had a patchy compliance run.
In a surprise to the market, Dr Reddy’s and Hikma have prevailed in challenging six method-of-use patents shielding Amarin’s Vascepa in the US, opening the door for a potential at-risk launch that would likely be challenged by the originator.
Duo will study up to four novel preclinical targets identified by Sitryx that may lead to potential new drugs for autoimmune diseases, which Lilly would then commercialize.